ResistanceMap
Exploring more than 50 surveillance indicators from North America and Europe
> GRAM-POSITIVE BACTERIA
>> S. aureus
>> S. pneumoniae
>> Enterococcus spp.
>> Coagulase-negative staphylococci
> GRAM-NEGATIVE BACTERIA
>> E. coli
>> K. pneumoniae
>> P. aeruginosa
>> A. baumannii
>> P. mirabilis
Exploring more than 50 surveillance indicators from North America and Europe
|
|
>> Resistance Overview
> GRAM-POSITIVE BACTERIA
>> S. aureus |
|
>> S. pneumoniae |
|
>> Enterococcus spp. |
|
>> Coagulase-negative staphylococci |
|
> GRAM-NEGATIVE BACTERIA
>> E. coli |
>> K. pneumoniae |
>> P. aeruginosa |
>> A. baumannii |
>> P. mirabilis |
|
> ABOUT ResistanceMap is a web-based collection of tools that allow accessible, engaging, and interactive exploration of more than 50 antimicrobial surveillance indicators from North America and Europe. Researchers, policymakers, and the public can use the Map to gain insight into the trends and magnitude of an unfolding public health crisis. To reach a wider audience, visualizations may be reembedded on any blog or website. Read more >>
> DATA AND METHODOLOGYResistanceMap draws from several microbiological surveillance databases. The information is abstracted to allow national and sub-national comparisons. Sources are credited in every visualization. The tool is powered by a Geovisual Analytics Visualization (GAV) platform, a flash-based technology that allows for the interactive exploration of multidimensional data. The intuitive layout is complemented by a help system that can be accessed by clicking the Read more >>> KEY FINDINGSGram-positive bacteria in the United States were more resistant than those in Europe or Canada; Levels of methicillin-resistant S. aureus (MRSA) are declining, but remain high. Rates of vancomycin-resistant enterococci (VRE) and macrolide-resistant pneumococci were among the highest in the developed world. Gram-negative species were less resistant by global standards, but displayed an alarming upward trend in resistance to multiple drugs. Enterobacteriaceae (E. coli, K. pneumoniae, P. mirabilis) are rapidly gaining resistance, including to drugs of last-resort. Of note is the rising frequency of carbapenem- and multidrug-resistant A. baumannii outbreaks. Antibiotic use in the United States showed large regional variation, with states in the Southeast consuming at nearly twice the rate of those in the Northwest. Fewer prescriptions per capita were filled since the late 1990s. However, prescribers are switching to newer, broad-spectrum therapies (such as fluoroquinolones) and use last-resort drugs more frequently. Read more >>
|
